Abstract:Abstract The use of antibiotics to treat bacterial infections often imposes strong selection for antibiotic resistance. However, the prevalence of antibiotic resistance varies greatly across different combinations of pathogens and drugs. What underlies this variation? Systematic reviews, meta-analyses, and literature surveys capable of integrating data across many studies have tried to answer this question, but the vast majority of these studies have focused only on cases where resistance is common or problematic. Yet much could presumably be learned from the cases where resistance is infrequent or absent. Here we conducted a literature survey and a systematic review to study the evolution of antibiotic resistance across a wide range of pathogen-by-drug combinations (57 pathogens and 53 antibiotics from 15 drug classes). Using Akaike information criterion-based model selection and model-averaged parameter estimation we explored 14 different factors posited to be associated with resistance evolution. We find that the most robust predictors of high resistance are nosocomial transmission (i.e., hospital-acquired pathogens) and indirect transmission (e.g., vector-, water-, air-, or vehicle-borne pathogens). While the former was to be expected based on prior studies, the positive correlation between high resistance frequencies and indirect transmission is, to our knowledge, a novel insight. The most robust predictor of low resistance is zoonosis from wild animal reservoirs. We also found partial support that resistance was associated with pathogen type, horizontal gene transfer, commensalism, and human-to-human transmission. We did not find support for correlations between resistance and environmental reservoirs, mechanisms of drug action, and global drug use. This work explores the relative explanatory power of various pathogen and drug factors on resistance evolution, which is necessary to identify priority targets of stewardship efforts to slow the spread of drug-resistant pathogens.

Evolution of drug-binding residues in bacterial ribosomes

Antibiotic Resistance Mechanisms, with an Emphasis on Those Related to the Ribosome

Ribosome-targeting antibiotics and mechanisms of bacterial resistance

The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics

High-resolution landscape of an antibiotic binding site

Macrolide antibiotic interaction and resistance on the bacterial ribosome

Growth-dependent bacterial susceptibility to ribosome-targeting antibiotics

Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design

Potential Key Bases Of Ribosomal Rna To Kingdom-Specific Spectra Of Antibiotic Susceptibility And The Possible Archaeal Origin Of Eukaryotes

The evolution of diverse antimicrobial responses in vancomycin-intermediate and its therapeutic implications

Dynamics of drug delivery determines course of evolution of antibiotic responses in bacteria

Evolutionary trajectories of β-lactam resistance in strains

Exceptions to the rule: When does resistance evolution not undermine antibiotic therapy in human bacterial infections?

Evolutionary trajectories of β-lactam resistance in Enterococcus faecalis strains

RNA polymerase stalling-derived genome instability underlies ribosomal antibiotic efficacy and resistance evolution

Direct visualization of ribosomes in the cell-free system revealed the functional evolution of aminoglycoside

Hibernating ribosomes as drug targets?

Laboratory Evolution of Antimicrobial Resistance in Bacteria to Develop Rational Treatment Strategies

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis

Antibiotic resistant characteristics from 16S rRNA

Evolution and evolvability of rifampicin resistance across the bacterial tree of life